130 related articles for article (PubMed ID: 1356562)
21. Effects of chronic alpha 2-adrenoceptor blockade on platelet and lymphocyte adrenoceptor binding in normal volunteers.
Glue P; Payvandi N; Kay G; Elliott JM; Nutt DJ
Life Sci; 1991; 49(8):PL21-5. PubMed ID: 1678132
[TBL] [Abstract][Full Text] [Related]
22. Characterization and autoradiographical localization of non-adrenoceptor idazoxan binding sites in the rat brain.
Mallard NJ; Hudson AL; Nutt DJ
Br J Pharmacol; 1992 Aug; 106(4):1019-27. PubMed ID: 1356565
[TBL] [Abstract][Full Text] [Related]
23. Anxiogenic-like effects of yohimbine and idazoxan in two behavioral situations in mice.
Venault P; Jacquot F; Save E; Sara S; Chapouthier G
Life Sci; 1993; 52(7):639-45. PubMed ID: 8094225
[TBL] [Abstract][Full Text] [Related]
24. The effect of yohimbine, WY 26392 and idazoxan on sympathetic nerve activity.
Ramage AG; Tomlinson A
Eur J Pharmacol; 1985 Feb; 109(2):153-60. PubMed ID: 2859996
[TBL] [Abstract][Full Text] [Related]
25. Antagonism of alpha-adrenoceptor agonist-induced antinociception in the rat.
Hayes AG; Skingle M; Tyers MB
Neuropharmacology; 1986 Apr; 25(4):397-402. PubMed ID: 2872610
[TBL] [Abstract][Full Text] [Related]
26. Regional hemodynamic responses to adrenoceptor antagonism in conscious rats.
Gardiner SM; Bennett T
Am J Physiol; 1988 Oct; 255(4 Pt 2):H813-24. PubMed ID: 2902805
[TBL] [Abstract][Full Text] [Related]
27. Alpha 2-adrenoceptor-mediated inhibitory and excitatory effects of detomidine on rat gastric acid secretion.
Blandizzi C; Bernardini MC; Natale G; del Tacca M
J Pharm Pharmacol; 1990 Oct; 42(10):685-8. PubMed ID: 1982138
[TBL] [Abstract][Full Text] [Related]
28. Selective alpha 2-adrenoceptor blockade does not enhance glucose-evoked insulin release.
John GW; Doxey JC; Walter DS; Reid JL
Eur J Pharmacol; 1990 Oct; 187(3):531-6. PubMed ID: 1981556
[TBL] [Abstract][Full Text] [Related]
29. The alpha-2 antagonists idazoxan and rauwolscine but not yohimbine or piperoxan are anxiolytic in the Vogel lick-shock conflict paradigm following intravenous administration.
La Marca S; Dunn RW
Life Sci; 1994; 54(10):PL179-84. PubMed ID: 7906377
[TBL] [Abstract][Full Text] [Related]
30. Alpha 2-adrenoceptor modulation of rat ventral hippocampal 5-hydroxytryptamine release in vivo.
Tao R; Hjorth S
Naunyn Schmiedebergs Arch Pharmacol; 1992 Feb; 345(2):137-43. PubMed ID: 1349158
[TBL] [Abstract][Full Text] [Related]
31. The effect of some alpha-adrenoceptor antagonists on spontaneous myogenic activity in the rat portal vein and the putative involvement of ATP-sensitive K+ channels.
Schwietert R; Wilhelm D; Wilffert B; Van Zwieten PA
Eur J Pharmacol; 1992 Jan; 211(1):87-95. PubMed ID: 1352250
[TBL] [Abstract][Full Text] [Related]
32. The alpha 2-adrenoceptor antagonists idazoxan and yohimbine increase rates of DRL responding in rats.
Sanger DJ
Psychopharmacology (Berl); 1988; 95(3):413-7. PubMed ID: 2901129
[TBL] [Abstract][Full Text] [Related]
33. Species-selective binding of [3H]-idazoxan to alpha 2-adrenoceptors and non-adrenoceptor, imidazoline binding sites in the central nervous system.
Hussain JF; Kendall DA; Wilson VG
Br J Pharmacol; 1993 Jul; 109(3):831-7. PubMed ID: 8102937
[TBL] [Abstract][Full Text] [Related]
34. Endogenous opioids may be involved in idazoxan-induced food intake.
Jackson HC; Griffin IJ; Nutt DJ
Neuropharmacology; 1992 Aug; 31(8):771-6. PubMed ID: 1356252
[TBL] [Abstract][Full Text] [Related]
35. Effects of idazoxan on catecholamine systems in rat brain.
Walter DS; Flockhart IR; Haynes MJ; Howlett DR; Lane AC; Burton R; Johnson J; Dettmar PW
Biochem Pharmacol; 1984 Aug; 33(16):2553-7. PubMed ID: 6147143
[TBL] [Abstract][Full Text] [Related]
36. Heterogeneity of smooth muscle alpha adrenoceptors in rat tail artery in vitro.
Medgett IC; Langer SZ
J Pharmacol Exp Ther; 1984 Jun; 229(3):823-30. PubMed ID: 6144792
[TBL] [Abstract][Full Text] [Related]
37. Pharmacological characterization of [3H]idazoxan, [3H]RX821002 and p-[125I]iodoclonidine binding to alpha 2-adrenoceptors in rat cerebral cortical membranes.
Wallace DR; Muskardin DT; Zahniser NR
Eur J Pharmacol; 1994 Jun; 258(1-2):67-76. PubMed ID: 7925601
[TBL] [Abstract][Full Text] [Related]
38. Does [3H]2-methoxy-idazoxan (RX 821002) detect more alpha-2-adrenoceptor agonist high-affinity sites than [3H]rauwolscine? A comparison of nine tissues and cell lines.
Erdbrügger W; Raulf M; Otto T; Michel MC
J Pharmacol Exp Ther; 1995 Jun; 273(3):1287-94. PubMed ID: 7791100
[TBL] [Abstract][Full Text] [Related]
39. Alpha 2-adrenoceptor blockade, pituitary-adrenal hormones, and agonistic interactions in rats.
Haller J; Barna I; Kovács JL
Psychopharmacology (Berl); 1994 Aug; 115(4):478-84. PubMed ID: 7871092
[TBL] [Abstract][Full Text] [Related]
40. Neuronal responses to noradrenaline in the cerebral cortex: evidence against the involvement of alpha 2-adrenoceptors.
Bradshaw CM; Sheridan RD; Szabadi E
Br J Pharmacol; 1984 Jun; 82(2):453-8. PubMed ID: 6145471
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
